Skip to main content
. 2021 Dec 6;12:791648. doi: 10.3389/fphar.2021.791648

FIGURE 3.

FIGURE 3

An exosome inhibitor GW4869 attenuates eCIRP release. (A) RAW 264.7 cells were treated with PBS, LPS or LPS + GW4869. After 20 h eCIRP levels of the supernatants were assessed by Western blotting. Data are expressed as means ± SE (n = 4 samples/group). The groups were compared by two-way ANOVA and SNK method (* p < 0.05 vs PBS; # p < 0.05 vs LPS). (B) Mice were injected with PBS, LPS or LPS + GW4869. After 4 h the serum was harvested and eCIRP levels were assessed by ELISA. Data are expressed as means ± SE (n = 5 samples/group). The groups were compared by two-way ANOVA and SNK method (* p < 0.05 vs PBS; # p < 0.05 vs LPS). (C) Mice were subjected to sham surgery, CLP or CLP with GW4869 instillation. After 20 h the serum was harvested and eCIRP levels were assessed by ELISA. Data are expressed as means ± SE (n = 6 samples/group). The groups were compared by two-way ANOVA and SNK method (* p < 0.05 vs Sham; # p < 0.05 vs CLP).